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INTRODUCTION
Prostate cancer is a multifaceted disease in which genetic and environmental factors play an important role. Studies show that prostate cancer is the most common cancer in man over 50 years age and is shown to be the second most reason for death due to cancer (1) (2) (3) . Currently prostate cancer has various treatment options according to the stage and clinical course of the disease such as radical retropubic prostatectomy (RRP), bra chytherapy, external radiotherapy, hormone therapy and chemotherapy. Although there has been an increase in the early diagnosis and treatment rates in prostate cancer, there has been no significant decrease in mortality. This fact gives rise to the thought that clinically insignificant disease is being treated excessively and active follow up of these patients should be preferred instead of radical treatment. Active surveillance which was first described by Coo et al. (4, 5) aims to postpone radical treatment and prevent redundant early treatment. Active surveillance in prostate cancer has become popular in the last decade (6, 7) . Patients who are adequate for active surveillance are determined with criteria; appropriate prostate specific antigen (PSA) level, clinical stage and Gleason score in the biopsy (8) . However, there is no sufficient randomized data available for supporting these criteria. In our study, we retrospectively investigated patients diagnosed as having localized prostate cancer in which RRP was performed in relation to three different active surveillance criteria as established by Klotz, Soloway and D'Amico. We evaluated whether the pathology results obtained from the RRP specimens were correlated with these three active surveillance criteria.
MATERIALS AND METHODS
We evaluated 211 patients with localized prostate cancer diagnosis in which RRP was performed between 2007 and 2012 in Okmeydanı Training and Research Hospital/ Istanbul. Patients who underwent previous hormono therapy and/or 5-alfa reductase inhibitor or pelvic radiotherapy were excluded from the study. Clinical stages were determined using 2002 TMN classifi-cation. All the RRP operations were performed by the same urologist and all biopsy and RRP specimens were evaluated by the same pathologist. Since positive biopsy core number and tumor percentage were not present in most of the biopsy pathology results, these active surveillance criteria were not included in the study. The active surveillance criteria defined by Soloway (cT ≤ T2, PSA ≤ 15 ng/dl, biopsy Gleason score ≤ 6), Klotz (T1c-T2a; if age ≥ 70 PSA ≤ 15 ng/dl, if age < 70 PSA ≤ 10 ng/dl; if age ≥ 70 biopsy Gleason score ≤ 7 (3 + 4), if age < 70 biopsy Gleason score ≤ 6) and D'Amico (clinical stage T1c-T2a, PSA ≤ 10 ng/dl, biopsy Gleason score ≤ 6) were used in our study. Patients appropriated for the three active surveillance protocols were determined by retrospectively examination of the preoperative PSA value, clinical stage and biopsy Gleason score (Table 1 ate for active surveillance were investigated and high stage and/or high Gleason scores were detected in the range 39-56%. According to active surveillance criteria recommended by this study group (PSA < 4 ng/ml, cT1 and Gleason score < 7), the misstaging rate (7.2%) was found to be statistically significantly decreased. However, the patients' ratio appropriate for active surveillance was found to be decreased to 6.9% (12) and this rate seemed to be low. In fact in our study the rate of patients suitable for Soloway, Klotz, D'Amico active surveillance protocols were 64.9%, 55.9%, 51.2%, respectively. Most important reason for misstaging was determined to be low prostate cancer grade in the biopsy results. The misstaging rate in the biopsy grades with regard to prostatectomy specimen grade were 36.1%, 38.9% and 40.1%, respectively. Supporting our finding, Dall'Era et al. established in their study that the most important reason for changing from active surveillance to radical treatment was the increase in the Gleason grades in prostate biopsies repeated periodically and this ratio was reported to be 38% (13) . In another study performed by Carter et al. this ratio was found to be 30% (14) . In the light of these findings we believe that if tumor grade is detected more accurately at the beginning, approximately 30% of patients could be treated with active surveillance protocols instead of RRP without losing the chance of cure. Several studies have determined that the sensitivity of digital rectal examination is low in the diagnosis and staging of prostate cancer (15) (16) (17) . In our study patients with organ confined disease on digital rectal examination had local advanced disease in the prostatectomy pathology results with the rates 21.3%, 22.8%, and 23.3% according to Soloway, Klotz and D'Amico active surveillance groups, respectively. In agreement with this results the evaluation of the propriety of patients for active surveillance showed that there was a misstaging rate of 21.3%-23.3% with digital rectal examination and 36.1-40.1% with Gleason grade. In our study digital rectal examination was found to detect whether the disease is limited to the organ better than grade, however misstaging rates were very high. The final point in active surveillance is not pathological stage, but biochemical recurrence, metastasis and cancer related death. While radical prostatectomy can cure the disease without affecting the quality of life when performed by experienced surgeons, it is still debated whether one should risk this chance with active surveillance (18) . Warlick et al. compared 38 patients who underwent radical prostatectomy following active surveillance with 150 patients with similar characteristics in which radical prostatectomy was performed immediately. This study indicated that postponing prostate cancer surgery didn't risk the chance of cure, however the evident difference between the patient population in the groups decreases the credibility of the study (19) . In contrast, the Toronto active surveillance study followed 299 patients and they performed radical prostatectomy in 24 patients which showed progression; in 14 (14%) pT3 and in two (8%) N1 was detected and these rates are high (20) . This indicated the risk of losing the chance for curative treatment after active surveillance (21) (22) (23) 
CONCLUSION
All these findings show that there are serious problems in the selection of active surveillance patients. Also, there is no consensus in the follow up of active surveillance patient. Consequently the controversial status of active surveillance may result in various mood disorders in patients, and this psychological aspect should not be underestimated. After evaluating all the study results, it is evident that the data on radical surgery results following active surveillance in low risk prostate cancer patients are insufficient. At least one fourth of the pathological data are consistent with the need of treatment and it is unknown how this rate will change with longer surveillance periods and how this will affect the patient prognosis. Thus, there is no current data that postponing active treatment in these patients decreases the chance of cure. Since there are not sufficient randomized studies with adequate follow up periods, active surveillance should only be recommended to a well selected patient group and the patient should be informed about the inconsistencies about active surveillance and all the treatment options should be explained, and the decision should be up to the patient.
